PrEP is one of the most powerful tools in HIV prevention. Yet for many Black LGBTQ+ people, getting access to the medication is far harder than it should be.

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

Almost six in 10 adults diagnosed with mpox during the 2022 outbreak had lingering physical symptoms for 11 to 18 months after acute illness, a study published in Annals of Internal Medicine ...

A HIGHLY contagious Victorian disease now rife in the UK can silently rip through families while being mistaken as winter ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...

SCHOOLS and care homes could soon be under siege from a highly contagious Victorian disease, scientists have warned. Leading ...

Human immunodeficiency virus, also known as HIV, is a serious viral infection that attacks the body’s immune system. Without treatment, HIV can lead to many health problems, such as acquired ...

Please provide your email address to receive an email when new articles are posted on . Dermatomyositis complications can lead to hospitalization. Certain presentations upon hospitalization can ...

Health officials are warning about a surge in so-called “super flu” cases as a particularly aggressive strain drives higher-than-usual hospitalizations this season. Patients are reporting intense ...

The super flu strain is spreading widely around the country. The nation’s hospitalization rate went up by 14.3 % as of Friday, according to the Centers for Disease Control and Prevention. Public ...

The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...